Zomedica Total Assets Growth & History (ZOMDF)
Zomedica's total assets was $127.0M for fiscal 2025.
View full Zomedica company overviewZomedica annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $127.0M | −$80.3M | −38.74% |
| 2024 | 2024-12-31 | $207.4M | −$45.8M | −18.10% |
| 2023 | 2023-12-31 | $253.2M | −$26.4M | −9.45% |
| 2022 | 2022-12-31 | $279.6M | −$790,000 | −0.28% |
| 2021 | 2021-12-31 | $280.4M | $214.3M | +323.92% |
| 2020 | 2020-12-31 | $66.1M | $62.0M | +1481.26% |
| 2019 | 2019-12-31 | $4.2M | −$1.9M | −30.67% |
| 2018 | 2018-12-31 | $6.0M | $817,697 | +15.68% |
| 2017 | 2017-12-31 | $5.2M | $640,264 | +13.99% |
| 2016 | 2016-12-31 | $4.6M | — | — |
Zomedica quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $118.1M | −$18.3M | −13.43% |
| Q1 2026 | 2026-03-31 | $121.5M | −$21.5M | −15.01% |
| Q4 2025 | 2025-12-31 | $127.0M | −$80.3M | −38.74% |
| Q3 2025 | 2025-09-30 | $130.9M | −$83.2M | −38.86% |
| Q2 2025 | 2025-06-30 | $136.5M | −$83.4M | −37.93% |
| Q1 2025 | 2025-03-31 | $143.0M | −$100.7M | −41.32% |
| Q4 2024 | 2024-12-31 | $207.4M | −$45.8M | −18.10% |
| Q3 2024 | 2024-09-30 | $214.1M | −$60.9M | −22.15% |
| Q2 2024 | 2024-06-30 | $219.9M | −$54.9M | −19.98% |
| Q1 2024 | 2024-03-31 | $243.7M | −$35.9M | −12.84% |
| Q4 2023 | 2023-12-31 | $253.2M | −$26.4M | −9.45% |
| Q3 2023 | 2023-09-30 | $275.1M | −$7.2M | −2.57% |
| Q2 2023 | 2023-06-30 | $274.8M | −$700,000 | −0.25% |
| Q1 2023 | 2023-03-31 | $279.6M | $1.6M | +0.58% |
| Q4 2022 | 2022-12-31 | $279.6M | −$790,000 | −0.28% |
| Q3 2022 | 2022-09-30 | $282.3M | $4.8M | +1.73% |
| Q2 2022 | 2022-06-30 | $275.5M | −$4.9M | −1.74% |
| Q1 2022 | 2022-03-31 | $278.0M | −$2.5M | −0.88% |
| Q4 2021 | 2021-12-31 | $280.4M | $214.3M | +323.92% |
| Q3 2021 | 2021-09-30 | $277.5M | $220.9M | +390.25% |
| Q2 2021 | 2021-06-30 | $280.4M | $247.6M | +755.73% |
| Q1 2021 | 2021-03-31 | $280.5M | $275.4M | +5470.90% |
| Q4 2020 | 2020-12-31 | $66.1M | $62.0M | +1481.26% |
| Q3 2020 | 2020-09-30 | $56.6M | $50.0M | +756.21% |
| Q2 2020 | 2020-06-30 | $32.8M | $23.3M | +245.61% |
| Q1 2020 | 2020-03-31 | $5.0M | −$859,534 | −14.58% |
| Q4 2019 | 2019-12-31 | $4.2M | −$1.9M | −30.67% |
| Q3 2019 | 2019-09-30 | $6.6M | $2.4M | +57.76% |
| Q2 2019 | 2019-06-30 | $9.5M | $3.1M | +47.70% |
| Q1 2019 | 2019-03-31 | $5.9M | $998,506 | +20.40% |
| Q4 2018 | 2018-12-31 | $6.0M | $817,697 | +15.68% |
| Q3 2018 | 2018-09-30 | $4.2M | — | — |
| Q2 2018 | 2018-06-30 | $6.4M | — | — |
| Q1 2018 | 2018-03-31 | $4.9M | — | — |
| Q4 2017 | 2017-12-31 | $5.2M | $640,264 | +13.99% |
| Q4 2016 | 2016-12-31 | $4.6M | — | — |
Zomedica total assets trends
Over the last five fiscal years, Zomedica's total assets increased from $66.1M to $127.0M, a change of $60.9M. The latest reported quarter, Q2 2026, shows $118.1M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zomedica source filings ↗